191 related articles for article (PubMed ID: 35940448)
1. Comparison of polidocanol foam versus bleomycin polidocanol foam for treatment of venous malformations.
He B; Yang B; Nie QQ; Zhang JB; Chen J; Liu P; Fan XQ; Ye ZD
J Vasc Surg Venous Lymphat Disord; 2023 Jan; 11(1):143-148. PubMed ID: 35940448
[TBL] [Abstract][Full Text] [Related]
2. Comparison of bleomycin polidocanol foam vs electrochemotherapy combined with polidocanol foam for treatment of venous malformations.
Liu JW; Ni B; Gao XX; He B; Nie QQ; Fan XQ; Ye ZD; Wen JY; Liu P
J Vasc Surg Venous Lymphat Disord; 2024 Mar; 12(2):101697. PubMed ID: 37890588
[TBL] [Abstract][Full Text] [Related]
3. Interim results of bleomycin-polidocanol foam sclerotherapy as a highly efficient technique for venous malformations.
Yang X; Chen H; Gu H; Jin Y; Hu L; Hua C; Wang Y; Sun Y; Yu W; Lin X
J Vasc Surg Venous Lymphat Disord; 2020 Nov; 8(6):1066-1073. PubMed ID: 32284311
[TBL] [Abstract][Full Text] [Related]
4. Bleomycin Polidocanol Foam (BPF) Stability - In Vitro Evidence for the Effectiveness of a Novel Sclerosant for Venous Malformations.
Sun Y; Gu H; Yang X; Cai R; Shang Y; Hu L; Wang Y; Chen H; Lin X
Eur J Vasc Endovasc Surg; 2020 Jun; 59(6):1011-1018. PubMed ID: 32063463
[TBL] [Abstract][Full Text] [Related]
5. Percutaneous Sclerotherapy of Large Venous Malformations Using Consecutive Polidocanol and Bleomycin Foam: MR Imaging Volumetric and Quality-of-Life Assessment.
Fraissenon A; Fortin F; Durous V; Chauvel-Picard J; Gleizal A; Viremouneix L; Cabet S; Guibaud L
J Vasc Interv Radiol; 2024 Jan; 35(1):127-136.e1. PubMed ID: 37704038
[TBL] [Abstract][Full Text] [Related]
6. Sclerotherapy for congenital vascular malformations with mixing foam of polidocanol and liquid of bleomycin.
Yang WH; Xiang XJ; Li HL
Phlebology; 2023 Aug; 38(7):451-457. PubMed ID: 37318342
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcomes and predictors of bleomycin polidocanol foam sclerotherapy treatment response in venous malformations.
Ni B; Liu JW; Fan XQ; He B; Nie QQ; Ye ZD; Liu P; Wen JY
J Int Med Res; 2024 Jan; 52(1):3000605231223441. PubMed ID: 38258803
[TBL] [Abstract][Full Text] [Related]
8. Ultrasound-guided polidocanol foam sclerotherapy for treating venous malformations.
Kumar S; Bhavana K; Kumar S; Kumar P
J Clin Ultrasound; 2018 Jan; 46(1):23-31. PubMed ID: 29080330
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of polidocanol sclerotherapy in alleviating symptoms in patients with venous malformations.
Guzelbey T; Cingoz M; Erdim C; Mutlu IN; Kılıckesmez O
J Vasc Surg Venous Lymphat Disord; 2024 Mar; 12(2):101698. PubMed ID: 37890587
[TBL] [Abstract][Full Text] [Related]
10. Sclerotherapy Improves Symptoms in Patients with Small and Moderate Diameter Low-Flow Vascular Malformations: A Prospective Cohort Study.
Leal BAN; Procópio RJ; Dardik A; Navarro TP
Ann Vasc Surg; 2023 Feb; 89():68-77. PubMed ID: 37466046
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of Duplex-guided polidocanol foam sclerotherapy for venous malformations.
Ali H; Saleh M; Mohammed W
Int Angiol; 2017 Jun; 36(3):228-236. PubMed ID: 27362577
[TBL] [Abstract][Full Text] [Related]
12. Preliminary Experience With More Stable Polidocanol Foam in Sclerotherapy of Head and Neck Venous Malformations.
Chen AW; Liu SH; Huang YY; Wang T
Dermatol Surg; 2018 Nov; 44(11):1421-1426. PubMed ID: 29933299
[TBL] [Abstract][Full Text] [Related]
13. Sclerotherapy of Venous Malformations Using Polidocanol: Effectiveness, Safety, and Predictors of Outcomes and Adverse Events.
Schmitt N; Lorenz J; Hohenstatt S; Semmelmayer K; Ruping F; Hoffmann J; Günther P; Bendszus M; Möhlenbruch MA; Vollherbst DF
J Vasc Interv Radiol; 2023 Dec; 34(12):2103-2109. PubMed ID: 37640102
[TBL] [Abstract][Full Text] [Related]
14. Fluoroscopy-guided foam sclerotherapy with sodium morrhuate for peripheral venous malformations: Preliminary experience.
Li L; Feng J; Zeng XQ; Li YH
J Vasc Surg; 2009 Apr; 49(4):961-7. PubMed ID: 19341886
[TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of foam sclerotherapy for treatment of low-flow vascular malformations in children.
Markovic JN; Nag U; Shortell CK
J Vasc Surg Venous Lymphat Disord; 2020 Nov; 8(6):1074-1082. PubMed ID: 32284312
[TBL] [Abstract][Full Text] [Related]
16. Foam Sclerotherapy in the Treatment of Hemangiomas and Venous Malformations.
Yang C; Li M; Li X; Zhu J; Shu C
Dermatol Surg; 2023 Sep; 49(9):855-861. PubMed ID: 37432998
[TBL] [Abstract][Full Text] [Related]
17. A Novel Compound Sclerosant: Polidocanol-Bleomycin Foam.
Hanshu Z; Shaohua L; Anwei C
Dermatol Surg; 2020 Dec; 46(12):1712-1714. PubMed ID: 32769523
[TBL] [Abstract][Full Text] [Related]
18. Clinical results of polidocanol sclerotherapy in venous malformation treatment: Patient-perceived improvement and satisfaction.
Çay F; Altunbulak AY; Özbay Y; Eldem G; Çil BE; Vargel İ; Kutluk MT; Yalçın B; Peynircioğlu B
Phlebology; 2023 Feb; 38(1):36-43. PubMed ID: 36433742
[TBL] [Abstract][Full Text] [Related]
19. Prospective randomized efficacy of ultrasound-guided foam sclerotherapy compared with ultrasound-guided liquid sclerotherapy in the treatment of symptomatic venous malformations.
Yamaki T; Nozaki M; Sakurai H; Takeuchi M; Soejima K; Kono T
J Vasc Surg; 2008 Mar; 47(3):578-84. PubMed ID: 18295109
[TBL] [Abstract][Full Text] [Related]
20. Image Guided Sclerotherapy of Masseteric Venous Malformations.
Kumar S; Bhavana K; Kumar B; Sinha AK; Kumar P
Ann Otol Rhinol Laryngol; 2020 Jun; 129(6):548-555. PubMed ID: 31910645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
